BRANDES INVESTMENT PARTNERS, LP - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRANDES INVESTMENT PARTNERS, LP ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$17,817,522
-0.7%
472,488
-0.1%
0.35%
-3.6%
Q2 2023$17,937,059
+59.5%
472,899
+2.3%
0.36%
+51.0%
Q1 2023$11,244,498
-6.4%
462,356
+11.8%
0.24%
-28.9%
Q4 2022$12,009,347
-4.8%
413,545
-1.7%
0.34%
+1.8%
Q3 2022$12,609,000
-16.2%
420,582
+1.1%
0.33%
-10.1%
Q2 2022$15,043,000
-8.3%
415,989
+9.7%
0.37%
+4.3%
Q1 2022$16,410,000
-6.4%
379,322
+8.5%
0.35%
-7.9%
Q4 2021$17,524,000
+3.3%
349,716
+31.2%
0.38%
+3.8%
Q3 2021$16,962,000
-7.3%
266,560
+4.8%
0.37%
-9.6%
Q2 2021$18,304,000
-39.7%
254,360
-37.3%
0.41%
-43.3%
Q1 2021$30,333,000
+1.8%
405,474
-1.6%
0.72%
-6.5%
Q4 2020$29,799,000
+59.0%
412,210
+20.6%
0.77%
+18.5%
Q3 2020$18,746,000
-13.2%
341,766
+5.2%
0.65%
-1.5%
Q2 2020$21,606,000
+37.6%
324,942
+26.6%
0.66%
+19.6%
Q1 2020$15,707,000
+123.5%
256,655
+221.1%
0.55%
+229.3%
Q4 2019$7,029,000
+28.5%
79,942
+45.2%
0.17%
+18.4%
Q3 2019$5,469,000
-12.7%
55,065
-1.5%
0.14%
+1.4%
Q2 2019$6,264,000
-32.4%
55,905
-14.3%
0.14%
-35.3%
Q1 2019$9,269,000
+16.7%
65,264
-4.7%
0.22%
+6.4%
Q4 2018$7,940,000
+20.6%
68,517
+52.8%
0.20%
+35.6%
Q3 2018$6,585,000
-13.8%
44,851
+2.1%
0.15%
-13.4%
Q2 2018$7,642,000
+28.9%
43,921
-26.9%
0.17%
+35.4%
Q1 2018$5,929,000
-20.4%
60,054
-15.6%
0.13%
-15.9%
Q4 2017$7,451,000
+202.9%
71,163
+225.9%
0.15%
+202.0%
Q3 2017$2,460,00021,8360.05%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2017
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 582,409$90,011,00060.33%
GUARDIAN POINT CAPITAL, LP 70,000$10,819,00010.19%
Think Investments LP 186,373$28,804,0008.16%
Greywolf Capital Management LP 277,936$42,955,0007.45%
Valentine Capital Asset Management, Inc. 28,431$4,394,0004.91%
FORT, L.P. 63,675$9,841,0004.69%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 527,266$81,489,0003.63%
RPG Investment Advisory, LLC 60,910$9,413,0003.52%
Kerrisdale Advisers, LLC 81,996$12,672,0003.24%
Strategic Global Advisors, LLC 48,154$7,442,0003.17%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders